CHINA PHARMA HOLDINGS, INC. Stock-Based Compensation
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Stock-Based Compensation of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $0.00.
- CHINA PHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $0.00.
- CHINA PHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $0.00.
- CHINA PHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2014-03-31 was $128.02K, a 43.47% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- CHINA PHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2012 was $141.72K, a 27.76% decline from fiscal 2011.
- CHINA PHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2011 was $196.18K, a 43.20% decline from fiscal 2010.
- CHINA PHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2010 was $345.42K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | ||
| 2021-09-30 | $15.24K 10-Q · filed 2022-11-14 | |||
| 2014-03-31 | $128.02K 10-Q · filed 2014-05-15 | |||
| 2013-12-31 | $0.00 10-K · filed 2014-03-20 | |||
| 2013-03-31 | $226.49K 10-Q · filed 2014-05-15 | $226.49K derived: sum of 2 quarters · filed 2014-05-15 | $226.49K derived: sum of 3 quarters · filed 2014-05-15 | $311.72K derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $0.00 derived: sum of 2 quarters · filed 2014-03-20 | $85.23K derived: sum of 3 quarters · filed 2014-03-20 | $141.72K 10-K · filed 2014-03-20 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $85.23K derived: sum of 2 quarters · filed 2012-11-14 | $141.72K 10-Q · filed 2012-11-14 | $198.83K derived: sum of 4 quarters · filed 2012-11-14 |
| 2012-06-30 | $85.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $141.72K 10-Q · filed 2012-08-14 | $198.83K derived: sum of 3 quarters · filed 2012-08-14 | $255.94K derived: sum of 4 quarters · filed 2012-11-14 |
| 2012-03-31 | $56.49K 10-Q · filed 2012-05-14 | $113.60K derived: sum of 2 quarters · filed 2012-05-14 | $170.71K derived: sum of 3 quarters · filed 2012-11-14 | $210.77K derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-12-31 | $57.11K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $114.22K derived: sum of 2 quarters · filed 2012-11-14 | $154.28K derived: sum of 3 quarters · filed 2012-11-14 | $196.18K 10-K · filed 2012-03-14 |
| 2011-09-30 | $57.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $97.18K derived: sum of 2 quarters · filed 2012-11-14 | $139.07K 10-Q · filed 2012-11-14 | $202.90K derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $40.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $81.97K 10-Q · filed 2012-08-14 | $145.79K derived: sum of 3 quarters · filed 2012-08-14 | $206.28K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $41.90K 10-Q · filed 2012-05-14 | $105.73K derived: sum of 2 quarters · filed 2012-05-14 | $166.21K derived: sum of 3 quarters · filed 2012-05-14 | |
| 2010-12-31 | $63.83K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | $124.31K derived: sum of 2 quarters · filed 2012-03-14 | $345.42K 10-K · filed 2012-03-14 | |
| 2010-09-30 | $60.49K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-06 | $281.59K 10-Q/A · filed 2012-03-06 | ||
| 2010-06-30 | $221.10K 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |